Sam Levine

Sam Levine is an accomplished director with extensive experience in the technology and healthcare sectors. Currently serving as Director at Mindbloom since 2021, Levine contributes to the world’s largest provider of psychedelic therapy, leveraging innovative treatments backed by prominent investors. Concurrently, Levine holds a director position at PAX, a leading technology-focused cannabis brand. Previous roles include Head of Strategy and Operations at Seso Inc., where Levine focused on labor solutions for agriculture, and Advisor at Redesign Health, which drives innovation in healthcare. As Co-Founder of Candid, Levine played a key role in transforming oral health care through technology. Early career experiences include positions at Eton Park and Blackstone, along with a foundational role at the Federal Reserve Board. Levine holds a Master’s degree in Financial Economics from the University of Oxford and dual Bachelor’s degrees from the University of Pennsylvania in Systems Science and Engineering and Finance, complemented by a minor in Mathematics.